methamphetamine has been researched along with butaclamol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lovenberg, W; Schmidt, CJ | 1 |
Sonsalla, PK; Terleckyj, I | 1 |
2 other study(ies) available for methamphetamine and butaclamol
Article | Year |
---|---|
In vitro demonstration of dopamine uptake by neostriatal serotonergic neurons of the rat.
Topics: Animals; Butaclamol; Citalopram; Clomipramine; Corpus Striatum; Dopamine; In Vitro Techniques; Methamphetamine; Nalidixic Acid; Naphthyridines; Propylamines; Serotonin | 1985 |
The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
Topics: Animals; Anticonvulsants; Antipsychotic Agents; Brain Diseases; Butaclamol; Carbazoles; Dizocilpine Maleate; Dopamine; Dopamine Agents; Drug Interactions; Drug Synergism; Guanidines; Ligands; Male; Methamphetamine; Mice; MPTP Poisoning; Neostriatum; Piperidines; Psychotropic Drugs; Pyrimidines; Receptors, Dopamine; Receptors, sigma; Stereoisomerism; Tyrosine 3-Monooxygenase | 1994 |